Skip to main content
. 2022 Dec 31;18(4):696–710. doi: 10.1016/j.jtumed.2022.12.011

Table 5.

Summary of meta-analysis outcome.

Subgroup Analysis Cases Controls OR (95% CI) Heterogeneity I2 Egger's Testa
Pregnancy illnesses 857 6225 2.19 (1.37, 3.50) 67% P = 0.4154
Asthma 857 6225 3.55 (1.87, 6.75) 73% P = 0.3476
Tonsillitis 693 5748 2.23 (1.21, 4.12) 86% P = 0.0435
Bronchitis 516 4822 1.14 (0.61, 2.14) 89% P < 0.0001
Pneumonia 669 5522 2.69 (1.23, 5.87) 85% P = 0.3173
Urinary tract infection 747 6140 1.62 (1.15, 2.28) 27% P = 0.0224
Otitis media 489 4266 2.03 (0.98, 4.19) 65% P < 0.0001
Chicken pox/(or) Measles 748 6221 2.37 (1.21, 4.63) 86% P = 0.9880
Rubella 516 4822 1.28 (0.84, 1.96) 0% P < 0.0001
High fever 857 6233 2.00 (1.52, 2.64) 29% P = 0.0760
Renal disorder 380 1784 11.85 (1.32, 106.53) 68% P = 0.4894
GIT 692 5745 3.02 (1.63, 5.57) 69% P = 0.8796
Jaundice 176 923 1.12 (0.64, 1.94) 0% P < 0.0001
Medication during breast feeding 131 332 0.94 (0.41, 2.11) 0% P < 0.0001
Child medication 231 1293 3.03 (0.50, 18.29) 93% P = 0.1153
a

Egger's test for a regression intercept gave a P > 0.05, indicating no evidence of publication bias.